BRAF and central nervous system neoplasm: Less frequent activating BRAF mutations (e.g. V600K, V600D, V600M) have been observed in malignant melanoma [17-20] and other non-CNS tumors [4,21] but only rarely have been identified in primary CNS tumors [6].